Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Morgan

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Annals of Neurology|November 15, 2001
Immunopathology of secondary-progressive multiple sclerosisJ W Prineas, E E Kwon, E S Cho, et al.
The EMBO Journal|February 21, 1998
Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domainR Uellner, M J Zvelebil, J Hopkins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Systemic complement profiling in multiple sclerosis as a biomarker of disease stateG Ingram, S Hakobyan, C L Hirst, et al.
Biochemical and Biophysical Research Communications|October 29, 1998
Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysisD V Tambourgi, F C Magnoli, C W van den Berg, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1996
Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypassA Finn, B P Morgan, N Rebuck, et al.
Advances in Experimental Medicine and Biology|March 14, 1998
The glycosylation of the complement regulatory protein, human erythrocyte CD59P M Rudd, B P Morgan, M R Wormald, et al.
Pediatric Research|July 1, 1997
The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsisH A Lassiter, B M Walz, J L Wilson, et al.
Biochemical Society Transactions|February 5, 1998
Roles for glycosylation in the anti-inflammatory molecule CD59P M Rudd, B P Morgan, M R Wormald, et al.
The Journal of Biological Chemistry|March 14, 1997
The glycosylation of the complement regulatory protein, human erythrocyte CD59P M Rudd, B P Morgan, M R Wormald, et al.
Biochemistry|August 23, 1994
Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59P A van der Merwe, A N Barclay, D W Mason, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Annals of Neurology|November 15, 2001
Immunopathology of secondary-progressive multiple sclerosisJ W Prineas, E E Kwon, E S Cho, et al.
The EMBO Journal|February 21, 1998
Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domainR Uellner, M J Zvelebil, J Hopkins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Systemic complement profiling in multiple sclerosis as a biomarker of disease stateG Ingram, S Hakobyan, C L Hirst, et al.
Biochemical and Biophysical Research Communications|October 29, 1998
Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysisD V Tambourgi, F C Magnoli, C W van den Berg, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1996
Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypassA Finn, B P Morgan, N Rebuck, et al.
Advances in Experimental Medicine and Biology|March 14, 1998
The glycosylation of the complement regulatory protein, human erythrocyte CD59P M Rudd, B P Morgan, M R Wormald, et al.
Pediatric Research|July 1, 1997
The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsisH A Lassiter, B M Walz, J L Wilson, et al.
Biochemical Society Transactions|February 5, 1998
Roles for glycosylation in the anti-inflammatory molecule CD59P M Rudd, B P Morgan, M R Wormald, et al.
The Journal of Biological Chemistry|March 14, 1997
The glycosylation of the complement regulatory protein, human erythrocyte CD59P M Rudd, B P Morgan, M R Wormald, et al.
Biochemistry|August 23, 1994
Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59P A van der Merwe, A N Barclay, D W Mason, et al.
Pageof 25